Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles.
Arris, C.E., Boyle, F.T., Calvert, A.H., Curtin, N.J., Endicott, J.A., Garman, E.F., Gibson, A.E., Golding, B.T., Grant, S., Griffin, R.J., Jewsbury, P., Johnson, L.N., Lawrie, A.M., Newell, D.R., Noble, M.E.M., Sausville, E.A., Schultz, R., Yu, W.(2000) J Med Chem 43: 2797
- PubMed: 10956187 
- DOI: 10.1021/jm990628o
- Primary Citation of Related Structures:  
1E1X, 1E1V - PubMed Abstract: 
Substituted guanines and pyrimidines were tested as inhibitors of cyclin B1/CDK1 and cyclin A3/CDK2 and soaked into crystals of monomeric CDK2. O6-Cyclohexylmethylguanine (NU2058) was a competitive inhibitor of CDK1 and CDK2 with respect to ATP (Ki v ...